A patient with refractory bradycardia dependent polymorphic ventricula
r tachycardia (PMVT) underwent permanent pacemaker placement for suppr
ession of her arrhythmia. Following implant, the patient had recurrent
PMVT. Interrogation of the device revealed a factory programmed featu
re (+ PVARP on PVC) designed to prevent pacemaker-mediated tachycardia
that led to cycle length variability and subsequent arrhythmia recurr
ence. This feature was deactivated and the patient's arrhythmia did no
t recur.